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Neonatal Marfan syndrome (nMFS) is far less common than the classic type and is con-
sidered to be a separate clinical entity, with its unique symptoms, specific mutations in the 
FBN1 gene, and extremely poor prognosis. So far, all reported cases have been sporadic and 
resulted from de novo mutations in the region encompassing exons 24–32 of the FBN1 gene. 
The lifespan of the affected newborns is greatly diminished due to rapidly progressive 
cardiovascular disease, entailing death within the first year of life for the majority of the 
cases. We present a patient with nMFS which was suspected prenatally based on serial 
ultrasound and targeted echocardiography examinations. To the best of our knowledge, 
this has been the tenth case of MFS diagnosed prenatally reported so far in the literature, 
and the fifth with the diagnosis being confirmed by molecular testing.
A 34-year-old secundipara (history of 1 uncomplicated pregnancy, spontaneous term 
delivery, healthy newborn, normal development) was referred at 24 weeks to our Department 
for detailed ultrasound due to protosystolic tricuspid regurgitation, choroid plexus bilateral 
cysts, and right kidney pyelectasis. First-trimester ultrasound screening showed no abnor-
malities and the risk of aneuploidy was calculated as low. nMFS was suspected based on 
cardiomegaly, regurgitation of the mitral, tricuspid and aortic valve (Figure 1), enlargement 
of the ascending aorta (Figure 2), dilatation of sinus Valsalva of the aorta with communication 
with the left ventricle, as well as humerus and femur length exceeding 2SD for gestational 
age, abnormal fetal profile and hand — with long fingers and contractures of the joints. The 
fetus (sex male) had detailed echocardiography monitoring in the second half of pregnancy 
due to progression of cardiomegaly, and echocardiographic features of congestive heart 
failure (Figure 3). Despite transplacental treatment with digoxin, fetal demise occurred at 
35 weeks of gestation. The post mortem inspection revealed the following: down-slanting 
palpebral fissures, crumpled ears, micrognathia, hand joint contractures (Figure 4), senile 
look, tall stature, arachnodactyly (hand middle finger of 4 cm with mean value for gestational 
age of 2.6–2.7 cm), elongated extremities, as well as prenatally described cardiac anoma-
lies. A skin fragment sampled during autopsy was used for fibroblasts culture. DNA isolated 
from skin fibroblasts was consecutively subjected to array CGH and sequence analysis of the 
FBN1 gene. Array CGH with the cut-off value of 200.000 bp did not detect any deletions or 
duplications. On the contrary, sequencing of genomic DNA comprising coding region of the 
FBN1 gene with neighboring intronic sequences using Sanger method on ABI3500 device 
revealed the presence of c.3964 + 1G > C heterozygous splice site mutation preceding 
exon 32, which predisposes to skipping exons during protein production, thus making the 
protein deficient. The same mutation was previously described in one patient with nMFS. 
Therefore, it is believed to be associated with severe phenotype of the affected individuals. 
Figure 1. Four chamber view 
at 24 weeks
Figure 3. Four chamber view 
at 35 weeks
Figure 2. Left ventricle 
outflow tract at 24 weeks
Figure 4. Neonatal Marfan  
syndrome features in the face 
and hand
